Mixed-affinity binding in humans with 18-kDa translocator protein ligands

Journal of Nuclear Medicine

Volumn 52, Issue 1, 2011, Pages 24-32

  Owen, David R J ^a,b   Gunn, Roger N ^b,c   Rabiner, Eugenii A ^b,c   Bennacef, Idriss ^b   Fujita, Masahiro ^d   Kreisl, William C ^d   Innis, Robert B ^d   Pike, Victor W ^d   Reynolds, Richard ^c   Matthews, Paul M ^b,c   Parker, Christine A ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Mixed affinity binding; Radioligand binding; TSPO

Indexed keywords

CARRIER PROTEIN; LIGAND;

ARTICLE; BINDING AFFINITY; BLOOD; BRAIN TISSUE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; KERNEL METHOD; LIGAND BINDING; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACETAMIDES; BINDING, COMPETITIVE; BRAIN; CARBON RADIOISOTOPES; HUMANS; ISOQUINOLINES; MOLECULAR WEIGHT; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, GABA;

EID: 79851473610     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.079459     Document Type: Article

References (13)

1. Banati RB, Newcombe J, Gunn RN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123:2321-2337.
2. 11C]DAA1106. Biol Psychiatry. 2008;64:835-841.
3. 11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage. 2008;39:1289-1298.
4. Fujita M, Imaizumi M, Zoghbi SS, et al. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage. 2008;40:43-52.
5. 11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage. 2009;49:2924-2932.
6. 3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab. 2010;30:1608-1618.
7. 18F-PBR06. J Nucl Med. 2009;50:1047-1053.
8. 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med. 2009;50:1276-1282.
9. Okubo T, Yoshikawa R, Chaki S, Okuyama S, Nakazato A. Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands. Bioorg Med Chem. 2004;12:423-438. (Pubitemid 38064214)
10. Selleri S, Gratteri P, Costagli C, et al. Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation. Bioorg Med Chem. 2005;13:4821-4834.
11. Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
12. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
13. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273-289. (Pubitemid 34852226)